Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Dec 23;73(5):e1181–e1190. doi: 10.1093/cid/ciaa1870

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America.

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

PMC Copyright notice

Figure 3. — Risk ratio and risk difference of antibacterial administration (oral and/or injectable), injectable antibacterial use, pneumonia, and additional antiinfluenza drug use regardless of hospitalization. (A) Oseltamivir vs baloxavir. (B) Zanamivir vs baloxavir. (C) Laninamivir vs baloxavir. ^aData were standardized using the inverse probability of treatment weighting method; the risk ratio was calculated using the exposed (baloxavir) group as the denominator and the neuraminidase inhibitor (NAI) group (oseltamivir, zanamivir, or laninamivir) as the numerator. Risk difference was the incidence of the outcome end point in the NAI group minus the incidence in the baloxavir group. ^bBaloxavir, N = 146 192; oseltamivir, N = 92 700. ^cBaloxavir, N = 240 341.4; oseltamivir, N = 238 657.8. ^dBaloxavir, N = 146 192; zanamivir, N = 18 677. ^eBaloxavir, N = 164 892.3; zanamivir, N = 163 701.7. ^fBaloxavir, N = 146 192; laninamivir, N = 81 438. ^gBaloxavir, N = 227 633.9; laninamivir, N = 227 618.3. Abbreviation: CI, confidence interval.